BR112017018272A2 - métodos de tratamento de diarréia e promoção de saúde intestinal em animais não humanos - Google Patents

métodos de tratamento de diarréia e promoção de saúde intestinal em animais não humanos

Info

Publication number
BR112017018272A2
BR112017018272A2 BR112017018272A BR112017018272A BR112017018272A2 BR 112017018272 A2 BR112017018272 A2 BR 112017018272A2 BR 112017018272 A BR112017018272 A BR 112017018272A BR 112017018272 A BR112017018272 A BR 112017018272A BR 112017018272 A2 BR112017018272 A2 BR 112017018272A2
Authority
BR
Brazil
Prior art keywords
young
spp
polymer composition
animals
diarrhea
Prior art date
Application number
BR112017018272A
Other languages
English (en)
Inventor
Hauser Michael
Martinod Serge
Original Assignee
Jaguar Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jaguar Health Inc filed Critical Jaguar Health Inc
Publication of BR112017018272A2 publication Critical patent/BR112017018272A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

são fornecidos métodos de tratamento de animais não humanos neonatos e jovens que sofrem de diarréia, e/ou seus sintomas, por administração a um animal necessitado de uma composição de polímero de proantocianidina isolada de um croton spp. ou um calophyllum spp. em particular, os animais neonatos e jovens incluem bezerros, equinos jovens e camelos jovens, que frequentemente sofrem de diarréia de várias etiologias, e a composição de polímero de proantocianidina administrada é isolada de croton lechleri. também são fornecidos métodos de aumento do ganho de peso e/ou redução da mortalidade em animais não humanos neonatos por administração da composição de polímero de proantocianidina. a composição, entérica ou não entérica, pode estar em forma solúvel aquosa e ser administrada oralmente aos animais neonatos e jovens afetados. a invenção também fornece composições pré-bióticas de extratos botânicos de croton spp. ou de calophyllum spp. úteis para promover uma microbiota intestinal benéfica.
BR112017018272A 2015-02-26 2016-02-24 métodos de tratamento de diarréia e promoção de saúde intestinal em animais não humanos BR112017018272A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562121308P 2015-02-26 2015-02-26
US201562172573P 2015-06-08 2015-06-08
US201562245862P 2015-10-23 2015-10-23
US201562255146P 2015-11-13 2015-11-13
PCT/US2016/019348 WO2016138125A1 (en) 2015-02-26 2016-02-24 Methods of treating diarrhea and promoting intestinal health in non-human animals

Publications (1)

Publication Number Publication Date
BR112017018272A2 true BR112017018272A2 (pt) 2018-04-10

Family

ID=56789179

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017018272A BR112017018272A2 (pt) 2015-02-26 2016-02-24 métodos de tratamento de diarréia e promoção de saúde intestinal em animais não humanos

Country Status (8)

Country Link
US (1) US20180028490A1 (pt)
CN (1) CN107427697A (pt)
AU (1) AU2016222791A1 (pt)
BR (1) BR112017018272A2 (pt)
CA (1) CA2976945A1 (pt)
HK (1) HK1246719A1 (pt)
UY (1) UY36569A (pt)
WO (1) WO2016138125A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200085885A1 (en) * 2016-12-21 2020-03-19 Cornell University Probiotic compositions and methods
CN108124788B (zh) * 2017-12-21 2021-03-30 李候梅 一种牛群监测方法
CN111526736B (zh) * 2017-12-27 2024-02-23 三得利控股株式会社 肠道屏障功能改善用组合物
CN109055517A (zh) * 2018-07-27 2018-12-21 成都大熊猫繁育研究基地 一种基于肠道微生物检测获得大熊猫饲喂食物配方的方法以及饲喂方法
US20220322707A1 (en) * 2019-08-14 2022-10-13 Locus Ip Company, Llc Drinkable Supplement Composition for Improved Health and Hydration
CN115053864A (zh) * 2022-06-24 2022-09-16 内蒙古大学 一种构建绵羊肠炎动物模型的方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5038396A (en) * 1983-10-03 1991-08-06 Mogens Gjerlov Preparation for rehydrating monogastric animals, including new-born calves, pigs and human beings suffering from diarrhoea and use thereof
JPH03120227A (ja) * 1989-10-02 1991-05-22 Shigeo Ochi 飲食物消化分解産物吸収抑制剤
AU4988197A (en) * 1996-10-16 1998-05-11 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compo sitions
US20060039899A1 (en) * 2004-08-23 2006-02-23 Winn Robert T Animal nutritional product that increases weight gain and reduces diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics
DE102010013209A1 (de) * 2010-03-29 2011-09-29 Technische Universität München Diarrhö-Prophylaktikum

Also Published As

Publication number Publication date
CN107427697A (zh) 2017-12-01
CA2976945A1 (en) 2016-09-01
WO2016138125A1 (en) 2016-09-01
HK1246719A1 (zh) 2018-09-14
UY36569A (es) 2016-09-30
AU2016222791A1 (en) 2017-09-07
US20180028490A1 (en) 2018-02-01

Similar Documents

Publication Publication Date Title
BR112017018272A2 (pt) métodos de tratamento de diarréia e promoção de saúde intestinal em animais não humanos
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
BR112013016936A2 (pt) métodos de usar oligossacarídeos de leite humano para melhorar a saúde respiratória das vias aéreas
BR112018000906A2 (pt) ?composto, medicamento, métodos de inibição da histona desacetilase em um mamífero, e para a profilaxia ou o tratamento de doenças, e, uso de um composto?
BR112019003410A2 (pt) composições e métodos para modulação da microflora gastrointestinal em um canino
BR112013031325A2 (pt) cepas / células lactobacilo secas por pulverização e seu uso contra helicobacter pylori
BR112017002325A2 (pt) produto farmacêutico adequado para administração oral, e composição farmacêutica
BR112016015660A2 (pt) formulação farmacêutica de neuregulina (nrg) e formulação farmacêutica liofilizada de neuregulina (nrg)
BR112017014343A2 (pt) composição contendo quitina e proteínas digeríveis
BR112018013227A2 (pt) ?composições farmacêuticas ou kit para o uso, métodos para tratar câncer em um mamífero e uso de uma composição?
CL2018001826A1 (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños
BR112017014649A2 (pt) ?isolado intestinal humano, e, composição?
BR112017017599A2 (pt) métodos para modular respostas imunológicas e inflamatórias pela administração de uma biomassa algal
BR112021025056A2 (pt) Mistura de extratos de planta para uso na prevenção e/ou tratamento de doenças intestinais inflamatórias crônicas
BR112018008040A2 (pt) composição nutricional compreendendo um hidrolisado de caseína, bem como um butirato dietético e/ou um composto para estimular a formação de butirato endógeno
BR112015019919A2 (pt) compostos bicíclicos
BR112017009267A2 (pt) métodos e composições para preservar a massa corporal magra e promover a perda de gordura durante a perda de peso
BR112015017544A2 (pt) composições que contêm sulfato de condroitina, enzimas proteolíticas e compostos de sulfidrila para melhorar a biodisponibilidade de sulfato de condroitina
BR112017007066A2 (pt) composições e métodos para melhorar a mobilidade ou a atividade, ou tratar a debilidade
BR112012033064A2 (pt) programação precoce de função cerebral através de alimentação com proteína de soja
MX2020013549A (es) Desarrollo de suplementos alimenticios para la salud y antioxidantes para controlar la hiperuricemia y el estrés oxidativo.
BR112017003548A2 (pt) tratamento de câncer com inibidor de alfa-amilase para animais de estimação
BR112016017765A8 (pt) composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso
BR112017023493A2 (pt) composições que compreendem cinamaldeído e zinco e métodos de uso de tais composições
BR112016029749A8 (pt) composição para perda de peso, composição que compreende cinamaldeído e zinco, seus usos, e método para fabricação de umm produto alimentício

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired